Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Analgesic Efficacy of SPSIP Block Versus Paravertebral Block Following Thoracotomy

NCT07275047 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-12-15
Last updated
2026-08-11

Condition(s) studied

Post-thoracotomy Pain

Investigational drug(s) / intervention(s)

Serratus Posterior Superior Intercostal Plane BlockThoracic Paravertebral Block

Serratus Posterior Superior Intercostal Plane Block: Ultrasound-guided regional anesthesia technique performed between the serratus posterior superior muscle and intercostal muscles.

Thoracic Paravertebral Block: Ultrasound-guided injection of local anesthetic into the thoracic paravertebral space to provide unilateral analgesia.

Study summary

Thoracotomy causes severe postoperative pain that may impair respiratory function and increase complications. This study compares the postoperative analgesic effectiveness of the serratus posterior superior intercostal plane (SPSIP) block and the paravertebral block in patients undergoing thoracotomy. The aim is to determine whether the newly described serratus posterior superior intercostal plane block can serve as a safe and effective alternative to established techniques.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Scheduled to undergo thoracotomy * ASA physical status I-III according to the American Society of Anesthesiologists classification * Able to understand the study procedures and provide written informed consent Exclusion Criteria: * Declines or is unable to provide informed consent * Allergy or hypersensitivity to local anesthetics or opioids * Known or suspected coagulopathy * Infection at the injection site * History of thoracic surgery * Severe cardiovascular disease * Hepatic or renal failure * Pregnant, suspected pregnancy, or breastfeeding Significant neurological or psychiatric disorder that may interfere with study participatio

Primary outcome measure(s)

  • Postoperative 24-Hour PCA Opioid Consumption — Postoperative 24 hours
    Total amount of opioid delivered by the patient-controlled analgesia (PCA) device during the first 24 hours after surgery, recorded in milligrams (mg).

Trial sites (1)

FacilityCityRegionStatus
Bursa City Hospital Bursa Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07275047 on ClinicalTrials.gov ↗ ← All trials in Turkey